Patent details

Basic Information

Publication number:

EP3086774

PCT Application Number:

US2014072319

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP148247497

PCT Publication Number:

WO2015100399

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ROMIDEPSIN FORMULATIONS AND USES THEREOF

French Title of Invention:

FORMULATIONS DE LA ROMIDEPSINE ET UTILISATIONS DE CELLES-CI

German Title of Invention:

ROMIDEPSINFORMULIERUNGEN UND VERWENDUNGEN DAVON

SPC Number:

Dates

Filing date:

24/12/2014

Grant date:

04/07/2018

EP Publication Date:

02/11/2016

PCT Publication Date:

02/07/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

04/07/2018

EP B1 Publication Date:

04/07/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

24/12/2018

Expiration date:

24/12/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/06/2018

 

 

Name:

Celgene Corporation

Address:

86 Morris Avenue, Summit, NJ 07901, United States (US)

Inventor

1

Name:

HUANG, Lianfeng

Address:

United States (US)

2

Name:

HUI, Ho-Wah

Address:

United States (US)

3

Name:

YANG, Gang

Address:

United States (US)

4

Name:

NARINGREKAR, Vijay

Address:

United States (US)

Priority

Priority Number:

201361921361 P

Priority Date:

27/12/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/00; A61K 47/12; A61K 47/10;

Publication

European Patent Bulletin

Issue number:

201827

Publication date:

04/07/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/04/2019	Outgoing Correspondence	1